万星控股(08093.HK)拟折让约18.03%增发2000万股 净筹499万港元
格隆汇11月22日丨万星控股(08093.HK)公告,于2019年11月22日,公司与认购人钟宝美订立认购协议,据此,根据认购协议所载条款及条件,认购人已有条件同意认购,而本公司已有条件同意配发及发行2000万股认购股份,认购价为每股认购股份0.25港元。认购价较11月22日公司收市价每股0.305港元折让约18.03%。
认购股份数目相当于配发扩大已发行股份总数约4.76%(假设于本公告日期至完成日期期间本公司已发行股本概无其他变动)。估计发行认购股份所得款项净额499万港元。公司拟将所得款项净额用作本集团一般营运资金及用于本集团业务未来发展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.